| bdc49ffe-81d9-4289-a62a-ced968c90f5f | Outros transtornos da hipófise | E236 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1799 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| dba36335-d36a-4405-95c1-3155ed0da631 | Transtorno não especificado da hipófise | E237 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1800 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 43752235-30f3-4b6b-9129-f31761c431e3 | Síndrome de cushing | E24 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12741 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 79a5f2f0-a6ea-4cd9-a726-e0168f355729 | Síndrome de Cushing dependente da hipófise | E240 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1801 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 5c2e950d-be11-4b96-9944-0117a9a3372b | Síndrome de Nelson | E241 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1802 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| a49c0b7d-4632-4272-b10b-bfa4a18ca47c | Síndrome de Cushing induzida por droga | E242 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1803 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 82fc5f88-2a5c-4809-8505-b8d3d4520cc8 | Síndrome do Acth ectópico | E243 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1804 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 031582a7-bd39-4c74-9798-0e13004eba7a | Síndrome de pseudo-Cushing induzida pelo álcool | E244 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1805 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| b9f9278f-0f2f-4fed-aec1-53bf13fc4775 | Outra síndrome de Cushing | E248 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1806 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 19b7ce42-3c35-4f32-a24e-eaf40f7e647c | Síndrome de Cushing não especificada | E249 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1807 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 1c776cd5-3cee-407b-8e33-129294b8c90f | Transtornos adrenogenitais | E25 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12742 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 6573df65-5701-480b-b6a4-3b988c1ee0c5 | Transtornos adrenogenitais congênitos associados à deficiência enzimática | E250 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1808 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 7c67d4c6-68ca-4262-b777-4d45216d597a | Outros transtornos adrenogenitais | E258 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1809 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| fc41defe-f415-49de-932e-a65dc5299838 | Transtorno adrenogenital não especificado | E259 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1810 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 02202051-b8cb-45be-ad05-00ca2bc21ca1 | Hiperaldosteronismo | E26 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12743 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 0643b01a-8c90-4f2c-b3d1-c792aa6f30ff | Hiperaldosteronismo primário | E260 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1811 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 56fa5cf5-9789-46e3-95a8-50140391a5f1 | Hiperaldosteronismo secundário | E261 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1812 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 921ecd27-b8d7-4ca6-8ceb-796fb5069169 | Outro hiperaldosteronismo | E268 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1813 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 8825b628-4266-4127-ba5a-59edbd653a64 | Hiperaldosteronismo não especificado | E269 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1814 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| f2e18c56-9cea-4615-b241-083396939739 | Outros transtornos da glândula supra-renal | E27 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12744 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| c84131f9-068d-41ae-b437-f6247ee5cfe5 | Outros excessos de atividade adrenocortical | E270 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1815 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| b773025e-8a9c-46d6-984a-ea10d910b4b1 | Insuficiência adrenocortical primária | E271 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1816 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| e5f3c858-f22a-46b2-827d-7351385fa51c | Coma hipoglicêmico não-diabético | E15 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1772 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 0653ffdc-235b-4ac0-9d24-e78f44335cc6 | Hipoglicemia induzida por droga sem coma | E160 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1773 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 982b3ea4-d040-4ed5-bf66-6f524dde7ae4 | Aumento da secreção de glucagon | E163 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1776 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 6c6709bd-92e0-4a89-af94-80b4cd2d0a79 | Outros transtornos da secreção pancreática interna | E16 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12736 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 6e75492d-0ed7-4cb9-9104-4dda4cd2dba2 | Outras insuficiências adrenocorticais e as não especificadas | E274 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1819 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| bbd9ea81-04d9-405d-a53e-f12e4620abce | Hiperfunção adrenomedular | E275 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1820 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| f4cf2e9b-9df3-4963-985f-9e2459ef118c | Outros transtornos especificados da supra-renal | E278 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1821 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 428e7c27-3fd0-479d-a17d-88aa633dc249 | Transtorno não especificado da supra-renal | E279 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1822 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 9b6cca43-63cf-4c9c-b4cd-33c7086182a3 | Deficiência de vitamina a com mancha de bitot e xerose conjuntival | E501 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1865 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 32fbd24c-bf75-4537-bfde-86106e1c81f9 | Adiposidade localizada | E65 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1913 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2025-01-17T12:57:40.683000+00:00 |
| 6f5838c2-66e0-401d-95bf-f989d8268784 | Obesidade devida a excesso de calorias | E660 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1914 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2025-03-13T13:13:02.274000+00:00 |
| 6f10cc56-78db-4c19-b6d7-4de7bcbf934b | Obesidade induzida por drogas | E661 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1915 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| b50e60c3-4667-494d-b8ad-b86178be1548 | Obesidade extrema com hipoventilação alveolar | E662 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1916 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 8c6d0ebb-3758-498a-9192-5b8c4bdca6e8 | Outros distúrbios do depósito de lípides | E755 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1959 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 3a27a982-1682-4c2e-8e45-1a1d9084367b | Distúrbio não especificado do depósito de lípides | E756 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 1960 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 50deff38-05d7-4149-a86f-6e38a08b98f4 | Amiloidose heredofamiliar neuropática | E851 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2005 | 1 | 2021-05-25T19:40:03.596000+00:00 | 2021-05-25T19:40:03.596000+00:00 |
| 587a5e27-25da-4642-b8bf-4df26e0850a7 | Amiloidose heredofamiliar não especificada | E852 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2006 | 1 | 2021-05-25T19:40:03.596000+00:00 | 2021-05-25T19:40:03.596000+00:00 |
| 2417b853-08e3-43aa-bda9-bf6053a6c6b3 | Delirium não induzido pelo álcool ou por outras substancias psicoativas | F05 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12783 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| fc75793e-8f9a-42e1-9424-cc8ba01e3148 | Delirium não superposto a uma demência, assim descrito | F050 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2054 | 1 | 2021-05-25T19:40:03.596000+00:00 | 2021-05-25T19:40:03.596000+00:00 |
| 40fc914b-1e58-4fde-878b-a2a8079eefb2 | Transtornos mentais e comportamentais devidos ao uso de opiáceos | F11 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 12787 | 1 | 2021-05-25T19:40:03.690000+00:00 | 2021-05-25T19:40:03.690000+00:00 |
| 5ecf0ffa-b49a-4ca5-a8ff-3a3bdbf817fc | Transtornos mentais e comport. dev. uso de opiáceos - intoxicação aguda | F110 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2084 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 7fff447d-c5f7-4cbe-a097-275a665831bc | Transtornos mentais e comport. dev. uso de opiáceos - uso nocivo para a saúde | F111 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2085 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 9bf81289-5bcb-4fa1-9d8d-fcc7be9c9541 | Transtornos mentais e comport. dev. uso de opiáceos - síndrome de dependência | F112 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2086 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 24c8668e-22b6-4364-9bcb-0ad817e0f9cf | Transtornos mentais e comport. dev. uso de opiáceos - síndrome [estado] de abstinência | F113 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2087 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 1db61e5b-60ef-4aa7-9f84-7afe8d44b946 | Transtornos mentais e comport. dev. uso de opiáceos - síndrome de abstin. com delírio | F114 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2088 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| eb87936a-0a05-4b0d-9f37-bde58cc45db0 | Transtornos mentais e comport. dev. uso de opiáceos - transtorno psicótico | F115 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2089 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 9f3b3dd3-687d-4933-9fcd-51d3ebbceed5 | Transtornos mentais e comport. dev. uso de opiáceos - síndrome amnésica | F116 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2090 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |
| 0c692512-7189-4aa1-9912-9d7995c6641f | Transtornos mentais e comport. dev. uso de opiáceos - outros transtornos mentais ou comportamentais | F118 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 2092 | 1 | 2021-05-25T19:40:03.597000+00:00 | 2021-05-25T19:40:03.597000+00:00 |